Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 123062993 | 12306299 | 3 | F | 201603 | 20160511 | 20160426 | 20160825 | EXP | US-JNJFOC-20160419558 | JANSSEN | 48.93 | YR | A | F | Y | 0.00000 | 20160825 | CN | US | US |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 123062993 | 12306299 | 1 | SS | DURAGESIC | FENTANYL | 1 | Transdermal | N | UNKNOWN;UNKNOWN;UNKNOWN | 0 | UNSPECIFIED | ||||||||
| 123062993 | 12306299 | 2 | SS | DURAGESIC | FENTANYL | 1 | Transdermal | N | UNKNOWN;UNKNOWN;UNKNOWN | 0 | UNSPECIFIED | ||||||||
| 123062993 | 12306299 | 3 | SS | DURAGESIC | FENTANYL | 1 | Transdermal | N | UNKNOWN;UNKNOWN;UNKNOWN | 0 | UNSPECIFIED | ||||||||
| 123062993 | 12306299 | 4 | SS | DURAGESIC | FENTANYL | 1 | Transdermal | N | UNKNOWN;UNKNOWN;UNKNOWN | 0 | UNSPECIFIED | ||||||||
| 123062993 | 12306299 | 5 | SS | DURAGESIC | FENTANYL | 1 | Transdermal | N | UNKNOWN;UNKNOWN;UNKNOWN | 0 | UNSPECIFIED | ||||||||
| 123062993 | 12306299 | 6 | SS | DURAGESIC | FENTANYL | 1 | Transdermal | N | UNKNOWN;UNKNOWN;UNKNOWN | 0 | UNSPECIFIED | ||||||||
| 123062993 | 12306299 | 7 | SS | DURAGESIC | FENTANYL | 1 | Transdermal | N | UNKNOWN;UNKNOWN;UNKNOWN | 0 | UNSPECIFIED | ||||||||
| 123062993 | 12306299 | 8 | SS | DURAGESIC | FENTANYL | 1 | Transdermal | N | UNKNOWN;UNKNOWN;UNKNOWN | 0 | UNSPECIFIED | ||||||||
| 123062993 | 12306299 | 9 | PS | DURAGESIC | FENTANYL | 1 | Transdermal | N | UNKNOWN;UNKNOWN;UNKNOWN | 19813 | UNSPECIFIED | ||||||||
| 123062993 | 12306299 | 10 | SS | DURAGESIC | FENTANYL | 1 | Transdermal | N | 1502578P1;UNKNOWN;UNKNOWN;UNKNOWN | 0 | MATRIX PATCH | ||||||||
| 123062993 | 12306299 | 11 | SS | DURAGESIC | FENTANYL | 1 | Transdermal | N | 1502578P1;UNKNOWN;UNKNOWN;UNKNOWN | 19813 | MATRIX PATCH | ||||||||
| 123062993 | 12306299 | 12 | SS | FENTANYL TRANSDERMAL SYSTEM | FENTANYL | 1 | Transdermal | 75 UG/HR AND 12.5 UG/HR | 0 | UNSPECIFIED | |||||||||
| 123062993 | 12306299 | 13 | SS | FENTANYL TRANSDERMAL SYSTEM | FENTANYL | 1 | Transdermal | 0 | UNSPECIFIED | ||||||||||
| 123062993 | 12306299 | 14 | SS | FENTANYL TRANSDERMAL SYSTEM | FENTANYL | 1 | Transdermal | 0 | UNSPECIFIED | ||||||||||
| 123062993 | 12306299 | 15 | SS | FENTANYL TRANSDERMAL SYSTEM | FENTANYL | 1 | Transdermal | 75 UG/HR AND 12.5 UG/HR | 0 | UNSPECIFIED | |||||||||
| 123062993 | 12306299 | 16 | C | CYMBALTA | DULOXETINE HYDROCHLORIDE | 1 | Oral | 0 | 90 | MG | TABLETS | QD | |||||||
| 123062993 | 12306299 | 17 | C | PERCOCET | ACETAMINOPHENOXYCODONE HYDROCHLORIDE | 1 | Oral | 0 | UNSPECIFIED |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 123062993 | 12306299 | 1 | Pain |
| 123062993 | 12306299 | 2 | Pain |
| 123062993 | 12306299 | 3 | Pain |
| 123062993 | 12306299 | 4 | Muscle disorder |
| 123062993 | 12306299 | 5 | Muscle disorder |
| 123062993 | 12306299 | 6 | Muscle disorder |
| 123062993 | 12306299 | 7 | Bone disorder |
| 123062993 | 12306299 | 8 | Bone disorder |
| 123062993 | 12306299 | 9 | Bone disorder |
| 123062993 | 12306299 | 10 | Myalgia |
| 123062993 | 12306299 | 11 | Bone pain |
| 123062993 | 12306299 | 12 | Myalgia |
| 123062993 | 12306299 | 13 | Myalgia |
| 123062993 | 12306299 | 14 | Bone pain |
| 123062993 | 12306299 | 15 | Bone pain |
| 123062993 | 12306299 | 16 | Pain |
| 123062993 | 12306299 | 17 | Pain |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 123062993 | 12306299 | OT |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 123062993 | 12306299 | Abasia | |
| 123062993 | 12306299 | Blister | |
| 123062993 | 12306299 | Breakthrough pain | |
| 123062993 | 12306299 | Drug ineffective | |
| 123062993 | 12306299 | Pain | |
| 123062993 | 12306299 | Pain of skin | |
| 123062993 | 12306299 | Pruritus | |
| 123062993 | 12306299 | Scab | |
| 123062993 | 12306299 | Swelling | |
| 123062993 | 12306299 | Temperature intolerance |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 123062993 | 12306299 | 10 | 201603 | 0 | ||
| 123062993 | 12306299 | 11 | 201603 | 0 | ||
| 123062993 | 12306299 | 12 | 201603 | 0 | ||
| 123062993 | 12306299 | 13 | 201603 | 201603 | 0 | |
| 123062993 | 12306299 | 14 | 201603 | 201603 | 0 | |
| 123062993 | 12306299 | 15 | 201603 | 0 | ||
| 123062993 | 12306299 | 16 | 2011 | 0 |